Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
Clinical trial NCT02630251 · TERMINATED
Trial details
- NCT number
- NCT02630251
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-25
- Primary completion
- 2018-12-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.